United States · Series B startup
2 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Imago BioSciences and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$67Mraised across 2 rounds since 2014, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $17M sold, first sale Mar 2019
From a historical funding recordSEC filing: $8.8M sold, first sale Oct 2014
From the SEC filings it signed: 2 on the team.
On the board, as filediDennis J. HennerDina Chaya MoghrabiHarish Chaya SoundararajanPatrick J. HeronRobert Chaya Baltera
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Frazier Healthcare Partners
Omega FundsL
Clarus Ventures
Merck Global Health Innovation Fund
AmgenAmgen Ventures
PharmaronGreenspringMissing a round, or an investor who was in one? Tell us.
Imago BioSciences's investors include Frazier Healthcare Partners, Omega Funds, Clarus Ventures, Merck Global Health Innovation Fund and Amgen, and 5 more on record. Omega Funds led its latest round.
Imago BioSciences has raised $67M across 2 rounds since 2014.
Imago BioSciences's most recent round was a Series B of $40M in Mar 2019, led by Omega Funds.
Its most recent round, $40M in Mar 2019, is also its largest on record.
Imago BioSciences's first round on record, in Oct 2014, was backed by Frazier Healthcare Partners, Clarus Ventures and Merck Global Health Innovation Fund and 1 others.
Imago BioSciences's latest named round is a Series B, in Mar 2019.
Imago BioSciences is based in the United States.
Omega Funds led the Series B in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
